Atea Pharmaceuticals, Inc. (AVIR) Profit Margin
Atea Pharmaceuticals, Inc. (AVIR) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | -22.51% |
| 2021-12-31 | 34.49% |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How AVIR compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| EXEL | Exelixis Inc. | 33.73% |
| VRTX | Vertex Pharmaceuticals Incorporated | 32.94% |
| LLY | Eli Lilly and Company | 31.67% |
| REGN | Regeneron Pharmaceuticals Inc. | 31.41% |
| GILD | Gilead Sciences Inc. | 28.90% |
These are five companies in the same sector as AVIR with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Atea Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("AVIR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AVIR | $5.05 | +0.60% | 0.18M |
| 3 | ||||
| 4 | ||||
| 5 |